Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Aleksander Krag, Helle Lindholm Schnefeld et al.|Clinical Gastroenterology and Hepatology|2025Cited by 33
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort studyNikolaj Torp, Maja Thiele, K. Bech et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 25